Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.
Mercogliano MF, Inurrigarro G, De Martino M, Venturutti L, Rivas MA, Cordo-Russo R, Proietti CJ, Fernández EA, Frahm I, Barchuk S, Allemand DH, Figurelli S, Deza EG, Ares S, Gercovich FG, Cortese E, Amasino M, Guzmán P, Roa JC, Elizalde PV, Schillaci R.
Mercogliano MF, et al. Among authors: guzman p.
BMC Cancer. 2017 Dec 28;17(1):895. doi: 10.1186/s12885-017-3897-x.
BMC Cancer. 2017.
PMID: 29281999
Free PMC article.